Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2016 Jan;21(1):171-82.
doi: 10.1111/adb.12192. Epub 2014 Oct 29.

Biobehavioral mechanisms of topiramate's effects on alcohol use: an investigation pairing laboratory and ecological momentary assessments

Affiliations
Randomized Controlled Trial

Biobehavioral mechanisms of topiramate's effects on alcohol use: an investigation pairing laboratory and ecological momentary assessments

Robert Miranda Jr et al. Addict Biol. 2016 Jan.

Abstract

Topiramate reduces drinking, but little is known about the mechanisms that precipitate this effect. This double-blind randomized placebo-controlled study assessed the putative mechanisms by which topiramate reduces alcohol use among 96 adult non-treatment-seeking heavy drinkers in a laboratory-based alcohol cue reactivity assessment and in the natural environment using ecological momentary assessment methods. Topiramate reduced the quantity of alcohol heavy drinkers consumed on drinking days and reduced craving while participants were drinking but did not affect craving outside of drinking episodes in either the laboratory or in the natural environment. Topiramate did not alter the stimulant or sedative effects of alcohol ingestion during the ascending limb of the blood alcohol curve. A direct test of putative mechanisms of action using multilevel structural equation mediation models showed that topiramate reduced drinking indirectly by blunting alcohol-induced craving. These findings provide the first real-time prospective evidence that topiramate reduces drinking by reducing alcohol's priming effects on craving and highlight the importance of craving as an important treatment target of pharmacotherapy for alcoholism.

Keywords: Craving; medication action; topiramate.

PubMed Disclaimer

Conflict of interest statement

Disclosure/Conflict of Interest

RS is a consultant for D&A Pharma, CT San Remo and Transcept Pharmaceuticals. Otherwise, the authors have no conflicts to disclose.

Figures

Figure 1
Figure 1
Participant flow through the randomized double-blind study; *One participant randomized to the topiramate condition did not consume alcohol while at the target dose and therefore was not included in analyses on subjective responses to alcohol. This participate was included in analyses of drinking outcomes.
Figure 2
Figure 2
Example illustration of the 2-1-1 mediation models. Medication Condition = randomly-assigned medication condition; Subjective Response to Alcohol = participant-reported subjective responses to alcohol (i.e., craving, stimulation, sedation) across drinking episodes; Drinking Outcome = participant-reported drinks per drinking day. Carryover effects of subjective response and drinking variables from study week 4 were controlled for in all models. For simplicity, these covariates are not shown.
Figure 3
Figure 3
Interaction plot between medication condition and drinking moment on alcohol craving in the natural environment; Nondrinking moment = ecological momentary assessments of craving recorded in the natural environment during all momentary reports prior to alcohol use on a given day; Drinking moment = ecological momentary assessments recorded in the natural environment while drinking alcohol.

Similar articles

Cited by

References

    1. Baltieri DA, Daró FR, Ribeiro PL, de Andrade AG. Comparing topiramate with naltrexone in the treatment of alcohol dependence. Addiction. 2008;103:2035–2044. - PubMed
    1. Carney MA, Tennen H, Affleck G, Del Boca FK, Kranzler HR. Levels and patterns of alcohol consumption using timeline follow-back, daily diaries and real-time “electronic interviews”. J Stud Alcohol. 1998;59:447–454. - PubMed
    1. Corrao G, Bagnardi V, Zambon A, La Vecchia C. A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med. 2004;38:613–619. - PubMed
    1. Davidson D, Camara P, Swift R. Behavioral effects and pharmacokinetics of low dose intravenous alcohol in humans. Alcohol Clin Exp Res. 1997;21:1294–1299. - PubMed
    1. Del Boca FK, Kranzler HR, Brown J, Korner PF. Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer. Alcohol Clin Exp Res. 1996;20:1412–1417. - PubMed

Publication types

LinkOut - more resources